As lung transplantation has become the most effective definitive treatment option for end-
stage chronic respiratory diseases, yearly rates of this surgery have been steadily …

Lung transplantation has become an established therapy for end-stage lung diseases. Early
postoperative complications can impact immediate, mid-term, and long-term outcomes …

Objective Lung ischemia-reperfusion injury is among the complications seen after lung
transplantation, resulting in morbidity and mortality. Pirfenidone, an antifibrotic agent for the …

Transplantation is a life-saving therapy for patients with end-stage organ disease.
Successful outcomes after transplantation require mitigation of the post-transplant …

Objective: The impact of previous lung volume reduction surgery (LVRS) or endoscopic lung
volume reduction (ELVR) on lung transplantation (LuTX) remains unclear. This study …

Lung ischemia-reperfusion (I/R) injury severely endangers human health, and recent studies
have suggested that certain microRNAs (miRNAs) play important roles in this pathological …

Primary graft dysfunction (PGD) is a form of acute lung injury that develops within the first 72
hours after lung transplantation. The overall incidence of PGD is estimated to be around …

With Tuberculosis (TB) affecting millions of people worldwide, novel imaging modalities and
tools, particularly nuclear medicine and molecular imaging, have grown with greater interest …

The development of targeted therapies has transformed the outlook for patients with
pulmonary arterial hypertension (PAH); however, some patients fail to achieve an adequate …

Lung transplant patients have the lowest long-term survival rates compared to other solid
organ transplants. The complications after lung transplantation such as primary graft …